[{"Assets_0_Q2_USD":2456228000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-102619000.0,"NetIncomeLoss_1_Q2_USD":-59806000.0,"NetIncomeLoss_2_Q2_USD":-140568000.0,"Ticker":"OPK","CIK":"944809","name":"OPKO HEALTH, INC.","OfficialName":"OPKO Health Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2187471532.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]